APA Citatie

Borsari, C., Rageot, D., Beaufils, F., Bohnacker, T., Keles, E., Buslov, I., . . . Wymann, M. P. (2019). Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl–Pyrimidine Moiety. ACS Med Chem Lett.

Chicago Style citaat

Borsari, Chiara, et al. "Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl–Pyrimidine Moiety." ACS Med Chem Lett 2019.

MLA citatie

Borsari, Chiara, et al. "Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl–Pyrimidine Moiety." ACS Med Chem Lett 2019.